Skip to main content

Labcorp vs Quest Diagnostics: Founders, CEOs and History

Labcorp was founded in 1995 by National Health Laboratories, Roche Biomedical Laboratories and is led by Adam H. Schechter. Quest Diagnostics was founded in 1967 by Dr. Paul A. Brown and is led by James Davis.

Company facts

Labcorp

Founded
1995
Headquarters
Burlington, North Carolina
Current CEO
Adam H. Schechter
Employees
71,000

Quest Diagnostics

Founded
1967
Headquarters
Secaucus, New Jersey, United States
Current CEO
James Davis
Employees
57,000

Founders

Labcorp

  • National Health Laboratories

    National Health Laboratories started as DCL BioMedical, a clinical laboratory business founded in 1968. Revlon acquired it in 1971 and renamed it in 1974; by 1977 it ran testing labs in 13 cities.

  • Roche Biomedical Laboratories

    Roche Biomedical Laboratories was Hoffmann-La Roche's US clinical testing subsidiary, based in Burlington, North Carolina.

Labcorp founders in full

Quest Diagnostics

  • Dr. Paul A. Brown

    Dr. Paul A. Brown founded Metropolitan Pathology Laboratory in 1967, which was renamed MetPath in 1969. He built it around centralized, automated, high-volume testing for physicians' offices instead of small local labs.

Quest Diagnostics founders in full

CEOs and their tenures

Labcorp

  1. David P. King2007–2019

    Former Chairman and CEO

    Expanded Labcorp from a US clinical lab into a combined diagnostics and drug development company.

    Source
  2. Adam H. Schechter2019–present

    Chairman and Chief Executive Officer

    Under Schechter revenue reached $13.95 billion in 2025 with adjusted EPS of $16.44, and 2026 guidance was raised to $18.10-$18.55 adjusted EPS.

    Source
Labcorp CEO history in full

Quest Diagnostics

  1. Kenneth W. Freeman1996–2004

    Chairman and CEO

    Freeman led Quest through the 1996 spin-off from Corning and the transformative 1999 SmithKline Beecham Clinical Laboratories acquisition. He established the acquisition-driven growth strategy and public company infrastructure.

    Source
  2. Surya Mohapatra2004–2012

    Chairman, President, and CEO

    Mohapatra expanded Quest's international presence and technology capabilities. He led the company through the AmeriPath acquisition and the 2008-2009 financial crisis, though growth slowed during his tenure.

    Source
  3. Steve Rusckowski2012–2022

    Chairman, President, and CEO

    Rusckowski transformed Quest into a leader in diagnostic information services with strong financial performance. He focused on health system partnerships, operational excellence, advanced diagnostics, and consumer testing.

    Source
  4. Jim Davis2022–present

    Chairman, CEO, and President

    Davis became CEO in November 2022 and Chairman in April 2023. He has led the LifeLabs acquisition, the Fresenius Spectra asset deal, the Corewell Health joint venture and further hospital outreach deals.

    Source
Quest Diagnostics CEO history in full

Timeline: Labcorp and Quest Diagnostics side by side

  1. 1967Quest Diagnostics

    Metropolitan Pathology Laboratory Founded by Dr. Paul A. Brown

    Dr. Paul A. Brown founded Metropolitan Pathology Laboratory, Inc. in Teaneck, New Jersey, to provide clinical laboratory services to local physicians and hospitals. The company was renamed MetPath, Inc. in 1969.

  2. 1971Labcorp

    Revlon acquires the NHL predecessor

    Revlon buys DCL BioMedical, a clinical lab business founded in 1968; it is renamed National Health Laboratories in 1974.

  3. 1982Quest Diagnostics

    Corning Glass Works Acquires MetPath

    Corning Glass Works acquired MetPath and renamed it Corning Clinical Laboratories.

  4. 1988Labcorp

    National Health Laboratories goes public

    NHL lists on NASDAQ, moving to the New York Stock Exchange in 1991.

  5. 1995Labcorp

    Merger creates Laboratory Corporation of America

    Roche contributes Roche Biomedical Laboratories and $186.7 million in cash for 49.9% of NHL Holdings; the combined company is renamed and moves to Burlington, North Carolina.

  6. 1996Quest Diagnostics

    Spin-off from Corning as Independent Public Company

    On December 31, 1996, Quest Diagnostics became an independent company through a spin-off from Corning and began trading on the NYSE under ticker DGX. Kenneth W. Freeman was appointed CEO.

  7. 1999Quest Diagnostics

    Acquisition of SmithKline Beecham Clinical Laboratories

    Quest acquired SmithKline Beecham Clinical Laboratories for approximately $1.3 billion in cash and stock.

  8. 2003Quest Diagnostics

    Acquisition of Unilab Corporation for $800 Million

    Quest acquired Unilab Corporation for $800 million, significantly expanding its West Coast presence and adding substantial volume in California and surrounding states.

  9. 2005Quest Diagnostics

    Acquisition of LabOne, Inc. for $934 Million

    Quest acquired LabOne, Inc. for $934 million, adding employer drug testing and paramedical testing capabilities that expanded the company's service offerings beyond traditional clinical laboratory testing.

  10. 2007Labcorp

    David P. King becomes CEO

    David P. King became CEO of Labcorp Holdings in 2007. Expanded Labcorp from a US clinical lab into a combined diagnostics and drug development company.

  11. 2007Quest Diagnostics

    Acquisition of AmeriPath for Approximately $1.23 Billion

    Quest acquired AmeriPath and its subsidiary Specialty Laboratories for approximately $1.23 billion, adding anatomic pathology and cancer diagnostic testing capabilities that complemented Quest's clinical chemistry strengths.

  12. 2011Quest Diagnostics

    Acquisitions of Athena Diagnostics and Celera Corporation

    Quest acquired Athena Diagnostics (neurodegenerative disease testing) and Celera Corporation (genomics and sequencing), adding advanced diagnostics capabilities in neurology and genetic testing that would become foundational for future growth initiatives.

  13. 2014Quest Diagnostics

    Acquisition of Solstas Lab Partners Group for $570 Million

    Quest acquired Solstas Lab Partners Group for $570 million, expanding its geographic footprint in the Southeastern United States and adding hospital outreach laboratory relationships.

  14. 2015Labcorp

    $6.1 billion Covance acquisition

    Labcorp buys contract research organization Covance, adding central laboratory and drug development services.

  15. 2016Labcorp

    Sequenom Acquired

    LabCorp bought the prenatal-testing company Sequenom in 2016.

  16. 2017Labcorp

    Chiltern Acquired

    LabCorp bought the contract research organisation Chiltern in 2017 for about $1.2 billion.

  17. 2018Quest Diagnostics

    Launch of QuestDirect Consumer-Initiated Testing

    Quest launched QuestDirect, a consumer-initiated testing service that allows patients to order health and wellness lab testing without a physician order in states where permitted. This marked Quest's entry into the direct-to-consumer diagnostic market.

  18. 2019Labcorp

    Adam H. Schechter becomes CEO

    Adam H. Schechter became CEO of Labcorp Holdings in 2019. Under Schechter revenue reached $13.95 billion in 2025 with adjusted EPS of $16.44, and 2026 guidance was raised to $18.10-$18.55 adjusted EPS.

  19. 2020Labcorp

    COVID-19 testing and at-home collection

    Labcorp receives FDA emergency use authorization for a SARS-CoV-2 test in March and launches the first at-home COVID-19 collection kit in April.

  20. 2020Quest Diagnostics

    COVID-19 Testing Launch and Pandemic Response

    Quest launched COVID-19 testing in March 2020 and by July 2020 had performed more than 9.2 million molecular tests and 2.8 million serology tests. The pandemic created both operational challenges and substantial revenue opportunities for the company.

  21. 2020Quest Diagnostics

    Acquisition of Blueprint Genetics for $108 Million

    Quest acquired Blueprint Genetics (Helsinki, Finland) for $108 million, adding genetic testing capabilities for rare diseases and expanding Quest's international genomics expertise.

  22. 2022Quest Diagnostics

    Jim Davis Becomes CEO, Succeeding Steve Rusckowski

    Jim Davis succeeded Steve Rusckowski as CEO on November 1, 2022, after serving as Executive Vice President of General Diagnostics. Davis brought experience from GE Healthcare, InSightec, and McKinsey & Company. He became Chairman on April 1, 2023.

  23. 2023Labcorp

    Fortrea spin-off

    Labcorp completes the June 2023 spin-off of its clinical development business as Fortrea Holdings (NASDAQ: FTRE).

  24. 2023Quest Diagnostics

    Acquisition of Haystack Oncology and NewYork-Presbyterian Outreach

    Quest acquired Haystack Oncology, a minimal residual disease testing company, and the outreach laboratory operations of NewYork-Presbyterian Hospital for $275 million, expanding advanced oncology diagnostics and health system partnerships.

  25. 2024Quest Diagnostics

    Acquisition of LifeLabs from OMERS for CAD $1.35 Billion

    Quest completed the acquisition of LifeLabs from OMERS for approximately CAD $1.35 billion (USD ~$1 billion), adding Canada's leading laboratory diagnostic provider with 6,500+ employees, 8+ million online portal users, and approximately CAD $970 million in an…

  26. 2025Labcorp

    $13.95 billion revenue and 750 million tests

    Labcorp grows revenue 7.2% to $13.95 billion, launches more than 130 new tests, and signs or closes 13 health-system and regional lab deals.

  27. 2025Quest Diagnostics

    Acquisition of Fresenius Medical Care Spectra Laboratories Assets

    Quest completed the acquisition of select clinical testing assets from Fresenius Medical Care's Spectra Laboratories and began providing comprehensive dialysis-related laboratory services for Fresenius-operated centers serving approximately 200,000 patients an…

  28. 2025Quest Diagnostics

    Record Financial Performance and Raised 2026 Guidance

    Quest reported record 2025 results with $11.035 billion in revenue (up 11.8%), operating income of $1.556 billion (up 15.6%), and cash from operations of $1.886 billion (up 41.4%).

  29. 2026Labcorp

    Guidance raised and buyback expanded

    After Q2 revenue of $3.73 billion, Labcorp raises 2026 guidance, adds $1.0 billion to its repurchase authorization, and launches Marker by Labcorp and ColoSense nationwide.

  30. 2026Quest Diagnostics

    Q1 2026 Results Raise Guidance

    Quest Diagnostics reports Q1 2026 revenues of $2.895B, 9.0% organic revenue growth, and raises FY2026 net revenue guidance to $11.78B-$11.90B.

  31. 2026Quest Diagnostics

    Q2 2026 Results and Second Guidance Raise

    Quest reported Q2 2026 revenue of $3.043B (up 10.2%, 10.0% organic) and adjusted diluted EPS of $3.12 (up 19.1%). It raised FY2026 revenue guidance to $11.95B-$12.05B. New York State approved Haystack MRD in the same period.

Acquisitions

Labcorp

  • Invitae (select assets)2024Undisclosed
  • BioReference Health (diagnostic business)2024Undisclosed
  • Personal Genome Diagnostics (PGDx)2022$450M
  • Sequenom Inc.2016$371M
  • Covance Inc.2015$6.1B
All Labcorp acquisitions

Quest Diagnostics

  • Spectra Laboratories (select assets from Fresenius Medical Care)2025Undisclosed
  • LifeLabs2024$1B
  • Haystack Oncology2023Undisclosed
  • Blueprint Genetics2020$108M
  • Solstas Lab Partners Group2014$570M
  • AmeriPath and Specialty Laboratories2007$1.2B
All Quest Diagnostics acquisitions

Questions about Labcorp vs Quest Diagnostics

Who is the CEO of Labcorp Holdings Inc. and Quest Diagnostics Incorporated?

Labcorp Holdings Inc. is led by Adam H. Schechter and Quest Diagnostics Incorporated is led by James Davis. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was Labcorp Holdings Inc. founded vs Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated was founded in 1967 — 28 years before Labcorp Holdings Inc., which was founded in 1995. Quest Diagnostics Incorporated's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Labcorp Holdings Inc..

How many employees does Labcorp Holdings Inc. have compared to Quest Diagnostics Incorporated?

Labcorp Holdings Inc. employs approximately 71,000 people, while Quest Diagnostics Incorporated employs approximately 57,000. Labcorp Holdings Inc. has the larger workforce at 71,000 employees, compared to Quest Diagnostics Incorporated's 57,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are Labcorp Holdings Inc. and Quest Diagnostics Incorporated headquartered?

Both Labcorp Holdings Inc. and Quest Diagnostics Incorporated are headquartered in United States. Their local rules and tax obligations may still differ.

Who founded Labcorp Holdings Inc. and Quest Diagnostics Incorporated?

Labcorp Holdings Inc. was founded by National Health Laboratories, Roche Biomedical Laboratories. Quest Diagnostics Incorporated was founded by Dr. Paul A. Brown.

Which company has a longer operating history — Labcorp Holdings Inc. or Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated has been operating for approximately 59 years, making it the more established of the two companies. Labcorp Holdings Inc. has been in operation for around 31 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Labcorp vs Quest Diagnostics overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.